NCT01448642View on ClinicalTrials.gov

Statins Evaluation in Coronary Procedures and Revascularization Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

4,191

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2017

Study Completion Date

April 30, 2018

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Atorvastatin

Atorvastatin loading dose of 80mg before PCI, reloading dose of 80mg 24 hours after PCI, and atorvastatin 40mg for 30 days

DRUG

Placebo

Matching placebo before PCI and 24 hours after PCI. Atorvastatin 40mg for 30 days

Trial Locations (1)

04005-000

Hospital do Coracao, São Paulo

All Listed Sponsors
collaborator

Ministry of Health, Brazil

OTHER_GOV

lead

Hospital do Coracao

OTHER

NCT01448642 - Statins Evaluation in Coronary Procedures and Revascularization Trial | Biotech Hunter | Biotech Hunter